European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Previous PostFermented Food Consumption Associated with Changes in the Gut Microbiome Next PostThe Global Prebiotic Association Welcomes FrieslandCampina Ingredients as a New Member You Might Also Like Hong Kong Researchers Examine Synbiotic Preparation for Post-COVID-19 Syndrome in Randomized, Double Blind, Placebo-Controlled Study January 17, 2024 How good gut bacteria help reduce the risk for heart disease July 14, 2020 Study Evaluates Impact of Administration of Oral Serum-Derived Bovine Immunoglobulin on Dysbiosis January 13, 2025
Hong Kong Researchers Examine Synbiotic Preparation for Post-COVID-19 Syndrome in Randomized, Double Blind, Placebo-Controlled Study January 17, 2024
Study Evaluates Impact of Administration of Oral Serum-Derived Bovine Immunoglobulin on Dysbiosis January 13, 2025